Solventum Co. (NYSE:SOLV) Given Consensus Rating of "Hold" by Brokerages

Shares of Solventum Co. (NYSE:SOLV - Get Free Report) have been assigned an average rating of "Hold" from the ten ratings firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $79.00.

Several equities research analysts have issued reports on SOLV shares. Morgan Stanley boosted their price target on shares of Solventum from $73.00 to $80.00 and gave the company an "equal weight" rating in a report on Wednesday, March 5th. Mizuho boosted their price target on shares of Solventum from $70.00 to $82.00 and gave the company a "neutral" rating in a report on Monday, March 3rd. Wells Fargo & Company boosted their price target on shares of Solventum from $73.00 to $75.00 and gave the company an "equal weight" rating in a report on Friday, February 28th. Piper Sandler lowered their price target on shares of Solventum from $80.00 to $78.00 and set a "neutral" rating on the stock in a report on Friday, May 9th. Finally, The Goldman Sachs Group boosted their price target on shares of Solventum from $63.00 to $71.00 and gave the company a "sell" rating in a report on Monday, March 3rd.

Solventum Price Performance

NYSE:SOLV opened at $70.95 on Thursday. The stock has a market cap of $12.27 billion and a P/E ratio of 32.85. Solventum has a one year low of $47.16 and a one year high of $85.92. The company has a fifty day moving average price of $69.93 and a 200 day moving average price of $71.28. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83.

Solventum (NYSE:SOLV - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $1.34 EPS for the quarter, beating the consensus estimate of $1.19 by $0.15. The company had revenue of $2.07 billion for the quarter, compared to analyst estimates of $2.02 billion. Solventum's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.08 earnings per share. Analysts anticipate that Solventum will post 6.58 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Rossby Financial LCC acquired a new position in Solventum during the 1st quarter worth about $25,000. Strengthening Families & Communities LLC lifted its position in Solventum by 376.8% during the 1st quarter. Strengthening Families & Communities LLC now owns 329 shares of the company's stock worth $25,000 after buying an additional 260 shares in the last quarter. Clarity Asset Management Inc. acquired a new position in Solventum during the 4th quarter worth about $25,000. Stonebridge Financial Group LLC acquired a new position in Solventum during the 4th quarter worth about $26,000. Finally, Raiffeisen Bank International AG acquired a new position in Solventum during the 4th quarter worth about $29,000.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.